Isosorbide mononitrate
Bidil, Ismotic, Isordil, Isosorbide, Monoket (isosorbide mononitrate) is a small molecule pharmaceutical. Isosorbide mononitrate was first approved as Ismotic on 1982-01-01. It is used to treat angina pectoris, coronary disease, cyanosis, diffuse esophageal spasm, and gastroesophageal reflux amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Monoket
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Isosorbide mononitrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MONOKET | Genus Lifesciences | N-020215 RX | 1993-06-30 | 2 products, RLD |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| ismo | 2007-03-31 | |
| ismotic | 2006-03-23 | |
| isosorbide | ANDA | 2017-07-06 |
| isosorbide mononitrate | ANDA | 2025-10-01 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
178 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart failure | D006333 | EFO_0003144 | I50 | 4 | 3 | 3 | 12 | 7 | 29 |
| Hypertension | D006973 | EFO_0000537 | I10 | 2 | 2 | 2 | 6 | 2 | 14 |
| Coronary artery disease | D003324 | — | I25.1 | 1 | — | — | 4 | 7 | 12 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | 1 | — | 1 | 4 | 4 | 10 |
| Coronary disease | D003327 | — | — | 1 | — | 1 | 3 | 3 | 8 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 1 | 2 | 4 | 7 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | — | — | 2 | 2 | 5 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | 2 | 2 | 4 |
| Stable angina | D060050 | — | I20.89 | — | — | 1 | 2 | 1 | 4 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | 3 | 1 | 4 |
Show 47 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | 1 | 1 | — | 3 | 5 |
| Syndrome | D013577 | — | — | — | — | 1 | — | 3 | 4 |
| Essential hypertension | D000075222 | — | I10 | — | 2 | 1 | — | — | 3 |
| Cerebral small vessel diseases | D059345 | — | — | — | 2 | 1 | — | 1 | 3 |
| Ischemia | D007511 | EFO_0000556 | — | — | — | 1 | — | 1 | 2 |
| Osteoporosis | D010024 | EFO_0003882 | M81.0 | — | — | 1 | — | 1 | 2 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 1 | — | 1 | 2 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | 1 | — | — | 2 |
| Cardio-renal syndrome | D059347 | — | — | — | — | 1 | — | 1 | 2 |
| Ventricular dysfunction | D018754 | — | — | — | — | 1 | — | 1 | 2 |
Show 22 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cervical ripening | D020070 | — | — | — | 1 | — | — | 2 | 3 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | — | — | — | 2 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 2 | — | — | — | 2 |
| Induced labor | D007751 | — | — | 1 | 2 | — | — | — | 2 |
| Missed abortion | D000030 | — | O02.1 | 1 | 1 | — | — | — | 2 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | 1 | — | — | 1 | 2 |
| Proteinuria | D011507 | — | R80 | — | 1 | — | — | — | 1 |
| Acute kidney injury | D058186 | — | N17 | — | 1 | — | — | — | 1 |
| Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | 1 | — | — | — | 1 |
| Wet macular degeneration | D057135 | EFO_0004683 | — | — | 1 | — | — | — | 1 |
Show 17 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 7 | — | — | — | 2 | 9 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 2 | — | — | — | — | 2 |
| Therapeutic equivalency | D013810 | — | — | 2 | — | — | — | — | 2 |
| Glucose metabolism disorders | D044882 | — | — | 1 | — | — | — | — | 1 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | 1 | — | — | — | — | 1 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | 1 | — | — | — | — | 1 |
| Fissure in ano | D005401 | — | K60.2 | 1 | — | — | — | — | 1 |
| Duchenne muscular dystrophy | D020388 | EFO_0000429 | — | 1 | — | — | — | — | 1 |
| Muscular dystrophies | D009136 | EFO_0000757 | G71.0 | 1 | — | — | — | — | 1 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
Show 1 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Membranous glomerulonephritis | D015433 | EFO_0004254 | N03.2 | — | — | — | — | 3 | 3 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 2 | 2 |
| Stomatognathic diseases | D009057 | — | K08.9 | — | — | — | — | 2 | 2 |
| Pancreatitis | D010195 | EFO_0000278 | K85 | — | — | — | — | 2 | 2 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | — | — | — | — | 2 | 2 |
| Headache | D006261 | — | R51 | — | — | — | — | 2 | 2 |
| Acute pain | D059787 | — | R52 | — | — | — | — | 2 | 2 |
| Neck pain | D019547 | — | M54.2 | — | — | — | — | 2 | 2 |
| Collateral circulation | D003097 | — | — | — | — | — | — | 1 | 1 |
| Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | — | — | 1 | 1 |
Show 107 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Isosorbide mononitrate |
| INN | isosorbide mononitrate |
| Description | Isosorbide mononitrate is a nitrate ester and a glucitol derivative. It has a role as a nitric oxide donor and a vasodilator agent. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O=[N+]([O-])O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12 |
Identifiers
| PDB | — |
| CAS-ID | 16051-77-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1311 |
| ChEBI ID | 6062 |
| PubChem CID | 27661 |
| DrugBank | DB01020 |
| UNII ID | LX1OH63030 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Isosorbide mononitrate
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 59,369 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
13,330 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use